Novel function for VEGF in breast carcinoma survival

VEGF 在乳腺癌生存中的新功能

• 批准号: 6919224
• 负责人: ROBIN Elizabeth BACHELDER
• 金额: $ 2.23万
• 依托单位: BETH ISRAEL DEACONESS MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2002
• 资助国家: 美国
• 起止时间: 2002-07-01 至 2005-08-17
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6919224
• 关键词: antisense nucleic acid; athymic mouse; autocrine; blocking antibody; breast neoplasms; carcinoma; cell line; cell migration; growth factor receptors; metastasis; neoplasm /cancer blood supply; neoplasm /cancer invasiveness; neoplastic process; nerve /myelin protein; phosphatidylinositol 3 kinase; vascular endothelial growth factors

DESCRIPTION (provided by applicant): The vascular endothelial growth factor (VEGF) is known to contribute to breast carcinoma progression by promoting angiogenesis. The current studies address a novel function for VEGF in promoting the invasion and migration of breast carcinoma cells. Specifically, this proposal addresses the hypothesis that VEGF secretion by breast carcinoma cells promotes their invasion by binding to VEGF receptors on the same or neighboring tumor cells. Moreover, it is hypothesized that this VEGF autocrine signaling contributes to breast carcinoma invasion by promoting the PI3-kinase-dependent migration of these cells. Using an antisense strategy, the effects of inhibiting VEGF expression on the invasion and migration of breast carcinoma cells in vitro will be explored. Moreover, the hypothesis that this autocrine signaling drives breast carcinoma invasion and migration by maintaining constitutively elevated levels of PI3-kinase activity in these cells will be explored. Finally, a role for the VEGF receptor neuropilin in this VEGF autocrine function will be examined. Specifically, the effects of neuropilin inhibitory antibodies, as well as deletion constructs that inhibit endogenous neuropilin function on breast carcinoma invasion and migration will be investigated. Finally, I will assess the effects of specifically inhibiting VEGF autocrine signaling in breast carcinoma cells on their growth and metastasis in immunodeficient mice. The characterization of this novel VEGF function will be critical in broadening our knowledge of the multiple steps involved in breast carcinoma progression.

描述（由申请人提供）：已知血管内皮生长因子（VEGF）通过促进血管生成促进乳腺癌进展。 目前的研究致力于VEGF在促进乳腺癌细胞侵袭和迁移中的新功能。 具体地说，该提议解决了乳腺癌细胞分泌VEGF通过与相同或相邻肿瘤细胞上的VEGF受体结合来促进其侵袭的假设。 此外，据推测，这种VEGF自分泌信号通过促进这些细胞的PI 3激酶依赖性迁移而有助于乳腺癌的侵袭。 采用反义策略，将探索抑制VEGF表达对乳腺癌细胞体外侵袭和迁移的影响。 此外，假设这种自分泌信号驱动乳腺癌的侵袭和迁移，维持组成性升高水平的PI 3-激酶活性在这些细胞将进行探讨。 最后，将检查VEGF受体神经纤毛蛋白在VEGF自分泌功能中的作用。 具体而言，将研究神经纤毛蛋白抑制性抗体以及抑制内源性神经纤毛蛋白功能的缺失构建体对乳腺癌侵袭和迁移的影响。 最后，我将评估特异性抑制乳腺癌细胞中VEGF自分泌信号对免疫缺陷小鼠生长和转移的影响。 这种新的VEGF功能的表征将是至关重要的，在扩大我们的知识的多个步骤参与乳腺癌的进展。